The team Cancer Immune Surveillance and Therapeutic Targeting is looking for a motivated young PhD aiming to work in a scientific but not conventional stimulating environment interfacing academic and private sectors. The candidate will make the bridge between fundamental research in the field of cancer immunology and development of therapeutic drugs in the field of immunotherapy by working in timeshare between the Cancer Research Center of Lyon in the Centre Léon Bérard and OSE immunotherapeutics®. More information
The postdoctoral researcher will be part of the Senescence, Cancer and Aging laboratory headed by David Bernard. He/she will develop a project investigating the role of new mechanisms controlling cellular senescence, in particular secreted factors, and decipher their impacts on tumor initiation and aging. More information
A full-time postdoctoral position is available in the « Molecular Regulation of Cancer Immunity » team of the Cancer Research Center of Lyon, France. The team studies the NF-kappaB family of transcription factors in T-cell biology, with focus on tumor immunity and autoimmune diseases. More information
The laboratory of Prof Julien C. Marie is seeking an experienced, creative and post- doctoral fellow to study the effects of TGF-b on T cell-biology in autoimmunity and anti-cancer response. A particular focus is proposed on deciphering mechanisms of action of TGF-b in using both in vitro and in vivo mouse models. More Information
Postdoctoral position – July2021
Decyphering the physical mechanisms of pyroptotic cell lysis / 2 years post-doctoral researcher.
The post-doctoral researcher will work under the guidance of Sylvain Monnier [Institut Lumière Matière (iLM)], Virginie Petrilli [Centre de recherche en cancérologie de Lyon (CRCL)] and Pierre Recho [Laboratoire Interdisciplinaire de physique (LIPhy)] in the framework of the ANR project SurVol coordinated by M. Piel. More Information
The “Genetics, epigenetics and biology of sarcoma” team led by Franck Tirode is looking for a postdoctoral fellow.
The project of the successful candidate, funded by the French National Cancer Institute (INCa) for 18 months, will aim at characterizing novel fusion genes in small round cell sarcoma with a particular focus on the chromatin remodeling deficiencies often observed in these rare sarcoma types. More information
We use coockies